Literature DB >> 26260601

Approaches to Assess Functional Selectivity in GPCRs: Evaluating G Protein Signaling in an Endogenous Environment.

Laura M Bohn1, Lei Zhou, Jo-Hao Ho.   

Abstract

Ligand-directed signaling, biased agonism, and functional selectivity are terms that describe the propensity of a ligand to drive signaling toward one GPCR pathway over another. Most of the early examples demonstrated to date examine the divergence between GPCR signaling to G protein coupling and βarrestin2 recruitment. As biased agonists begin to become available based on cell-based screening criteria, a need arises to determine if G protein signaling biases will be maintained in the endogenous setting, wherein receptors are functioning to control relevant biological responses. This report presents our method and offers tips for evaluating G protein signaling in endogenous tissues. Predominately, brain tissues are discussed here; optimization points that can be applied to any tissues are highlighted.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26260601      PMCID: PMC4804702          DOI: 10.1007/978-1-4939-2914-6_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  33 in total

1.  Interactions of the α-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials.

Authors:  Fotis A Baltoumas; Margarita C Theodoropoulou; Stavros J Hamodrakas
Journal:  J Struct Biol       Date:  2013-03-21       Impact factor: 2.867

Review 2.  Teaching old receptors new tricks: biasing seven-transmembrane receptors.

Authors:  Sudarshan Rajagopal; Keshava Rajagopal; Robert J Lefkowitz
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

Review 3.  Mammalian G proteins and their cell type specific functions.

Authors:  Nina Wettschureck; Stefan Offermanns
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

4.  Endomorphin-2: a biased agonist at the μ-opioid receptor.

Authors:  Guadalupe Rivero; Javier Llorente; Jamie McPherson; Alex Cooke; Stuart J Mundell; Craig A McArdle; Elizabeth M Rosethorne; Steven J Charlton; Cornelius Krasel; Christopher P Bailey; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2012-05-02       Impact factor: 4.436

5.  Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy.

Authors:  Rita Rahmeh; Marjorie Damian; Martin Cottet; Hélène Orcel; Christiane Mendre; Thierry Durroux; K Shivaji Sharma; Grégory Durand; Bernard Pucci; Eric Trinquet; Jurriaan M Zwier; Xavier Deupi; Patrick Bron; Jean-Louis Banères; Bernard Mouillac; Sébastien Granier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

6.  Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.

Authors:  Yulin Wang; Kang Tang; Saadet Inan; Daniel Siebert; Ulrike Holzgrabe; David Y W Lee; Peng Huang; Jian-Guo Li; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2004-09-21       Impact factor: 4.030

7.  Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons.

Authors:  Cullen L Schmid; John M Streicher; Chad E Groer; Thomas A Munro; Lei Zhou; Laura M Bohn
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

8.  Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.

Authors:  I Dennis; B J Whalley; G J Stephens
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

9.  Development of functionally selective, small molecule agonists at kappa opioid receptors.

Authors:  Lei Zhou; Kimberly M Lovell; Kevin J Frankowski; Stephen R Slauson; Angela M Phillips; John M Streicher; Edward Stahl; Cullen L Schmid; Peter Hodder; Franck Madoux; Michael D Cameron; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

Review 10.  Recent developments in biased agonism.

Authors:  James W Wisler; Kunhong Xiao; Alex R B Thomsen; Robert J Lefkowitz
Journal:  Curr Opin Cell Biol       Date:  2013-11-20       Impact factor: 8.382

View more
  8 in total

1.  Approaches to Assess Biased Signaling at the CB1R Receptor.

Authors:  Robert B Laprairie; Edward L Stahl; Laura M Bohn
Journal:  Methods Enzymol       Date:  2017-07-05       Impact factor: 1.600

2.  Crystal Structure of the Human Cannabinoid Receptor CB1.

Authors:  Tian Hua; Kiran Vemuri; Mengchen Pu; Lu Qu; Gye Won Han; Yiran Wu; Suwen Zhao; Wenqing Shui; Shanshan Li; Anisha Korde; Robert B Laprairie; Edward L Stahl; Jo-Hao Ho; Nikolai Zvonok; Han Zhou; Irina Kufareva; Beili Wu; Qiang Zhao; Michael A Hanson; Laura M Bohn; Alexandros Makriyannis; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

3.  G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.

Authors:  Jo-Hao Ho; Edward L Stahl; Cullen L Schmid; Sarah M Scarry; Jeffrey Aubé; Laura M Bohn
Journal:  Sci Signal       Date:  2018-08-07       Impact factor: 8.192

4.  Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.

Authors:  Joshua D Gross; Shane W Kaski; Karl T Schmidt; Elizabeth S Cogan; Kristen M Boyt; Kim Wix; Adam B Schroer; Zoe A McElligott; David P Siderovski; Vincent Setola
Journal:  Neuropsychopharmacology       Date:  2019-05-29       Impact factor: 7.853

5.  Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.

Authors:  Mariana Spetea; Shainnel O Eans; Michelle L Ganno; Aquilino Lantero; Michael Mairegger; Lawrence Toll; Helmut Schmidhammer; Jay P McLaughlin
Journal:  Br J Pharmacol       Date:  2017-06-27       Impact factor: 8.739

6.  Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation.

Authors:  Prashant Donthamsetti; Eduardo F Gallo; David C Buck; Edward L Stahl; Ying Zhu; J Robert Lane; Laura M Bohn; Kim A Neve; Christoph Kellendonk; Jonathan A Javitch
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

7.  Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice.

Authors:  Amelia D Dunn; Brian Reed; Catherine Guariglia; Alexandra M Dunn; Joshua M Hillman; Mary Jeanne Kreek
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

Review 8.  Community guidelines for GPCR ligand bias: IUPHAR review 32.

Authors:  Peter Kolb; Terry Kenakin; Stephen P H Alexander; Marcel Bermudez; Laura M Bohn; Christian S Breinholt; Michel Bouvier; Stephen J Hill; Evi Kostenis; Kirill A Martemyanov; Rick R Neubig; H Ongun Onaran; Sudarshan Rajagopal; Bryan L Roth; Jana Selent; Arun K Shukla; Martha E Sommer; David E Gloriam
Journal:  Br J Pharmacol       Date:  2022-03-27       Impact factor: 9.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.